Minerva Neurosciences Inc
NASDAQ:NERV

Watchlist Manager
Minerva Neurosciences Inc Logo
Minerva Neurosciences Inc
NASDAQ:NERV
Watchlist
Price: 3.88 USD -4.9% Market Closed
Market Cap: 27.1m USD

Operating Margin
Minerva Neurosciences Inc

0%
Current
0%
Average
-4.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-14.6m
/
Revenue
0

Operating Margin Across Competitors

No Stocks Found

Minerva Neurosciences Inc
Glance View

Market Cap
27.1m USD
Industry
Biotechnology

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. The company is headquartered in Waltham, Massachusetts and currently employs 9 full-time employees. The company went IPO on 2014-06-25. The firm is focused on the development and commercialization of product candidates to treat patients suffering from central nervous system (CNS) diseases. The firm's lead product candidates are roluperidone (MIN-101), seltorexant and MIN-301. Roluperidone (MIN-101) is a compound that blocks serotonin, sigma, and α adrenergic receptors that are involved in the regulation of mood, cognition, sleep, and anxiety. The firm is developing roluperidone to treat patients with schizophrenia. Roluperidone is designed to block a specific subtype of serotonin receptor called 5-HT2A. The firm is developing seltorexant for the treatment of insomnia disorder and adjunctive treatment of the major depressive disorder (MDD). MIN-301 is a soluble recombinant form of the Neuregulin-1b1 (NRG-1b1), protein, for the treatment of Parkinson’s disease and for other neurodegenerative disorders.

NERV Intrinsic Value
HIDDEN
Show
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-14.6m
/
Revenue
0
What is the Operating Margin of Minerva Neurosciences Inc?

Based on Minerva Neurosciences Inc's most recent financial statements, the company has Operating Margin of 0%.

Back to Top